Centiva Capital’s Cardinal Health CAH Stock Holding History

Centiva Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,000	Closed	-$144K	–	445
2019 Q1	$144K	Buy	+3,000	New	+$150K	0.01%	282

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Centiva Capital's CAH Position: Q2 2026 in Review

Centiva Capital sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,583 shares — an estimated $335K sold.

Centiva Capital first reported a position in CAH in Q1 2019 and held it in 17 quarters. The position peaked at $1.86M in Q1 2023. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Centiva Capital reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 1,583 Cardinal Health shares in Q2 2026, an estimated $335K.
Centiva Capital first reported a position in Cardinal Health in Q1 2019 and held it in 17 quarters.
Centiva Capital's Cardinal Health position peaked at $1.86M in Q1 2023.
1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.